ersonal use only

Financial Results

Presentation

Financial Year Ending September 2021

Platform set for FY22 and Beyond

HGL Ltd (ASX:HNG) Hancock & Gore

PERFORMANCE HIGHLIGHTS FOR THE YEAR ENDED 30TH SEPTEMBER 2021 (FY21)

ersonal use only

81%

SHAREHOLDER

RETURN

55%

NTA PER SHARE

GROWTH

94%

NPAT RETURN ON

NET ASSETS

24%

FUM

GROWTH

$15.6M NET PROFITAFTER TAX

$47.1M NTA

VALUE

~$0.26 NTA PER

SHARE

$0.01 FULLY FRANKEDDIVIDEND

ersonal use only

FY21 HIGHLIGHTS

Return to significant profitability - FY21 ~$15.6m NPAT

Resumed paying dividends - 1 cent per share fully franked declared. Franking Credit balance of $9.2m

Active transformation and value crystallisation of both JSB & BLC private investments releasing >$2m profit and liquidity in FOS Capital Ltd (FOS) and Cellmid Ltd (CDY) respectively

Realised > $1m profit from ASX Listed share portfolio - annualised IRR of > 50%

Acquisition of Funds Management Vehicle and relaunch of H&G High Conviction Fund. Fund achieved return of 18% in 6 months post acquisition

New Private Equity Investments - T-ShirtVentures & Mint Payments

Increase in valuation of Mountcastle & Pegasus reflecting underlying earnings growth

$5.8m EBIT generated by operating businesses (H&G share - no longer consolidated or equity accounted)

Strong Balance sheet - in excess of $7m Cash available - NTA approx. $0.26

INVESTMENT TEAM

70+ years of collective investment experience

ersonal use only

SANDY BEARD EXECUTIVE CHAIRMAN

  • 30+ years of investment experience and Director of numerous public and private companies.

NICHOLAS ATKINSON INVESTMENT DIRECTOR

  • 25+ years of experience across capital markets, corporate finance and investment management.
  • Former Executive Director of Institutional Equities at Morgans Financial (14 years).
  • MBA (Macquarie GSM)
  • Bachelor Commerce (UQ)
  • Grad Dip Applied Investment & Finance (FINSIA)

PHILLIP CHRISTOPHER INVESTMENT DIRECTOR

  • 12+ years of experience across private equity, capital markets and investment management.
  • Former Director at Alceon Group Private Equity (6 years) and Analyst at Goldman Sachs. Director of Cellmid Limited and Pegasus Healthcare
  • Bachelor of Economics and Bachelor of Commerce (University of Western Australia)

IAIN THOMPSON

CFO & COMPANY SECRETARY

  • 30+ years of finance and company secretarial experience, including 6 years at H&G
  • Former Company Secretary of Brickworks Limited (ASX:BKW)
  • Chartered Accountant (CA)
  • Bachelor of Economics (Macquarie University)
  • GAICD
  • Grad Dip Company Secretarial Practice

ersonal use only

PORTFOLIO ACTIVITY SETS STRONG PLATFORM FOR GROWTH IN FY22

LIQUIDITY REALISATIONS:

GROWTH/M&A:

NEW INVESTMENTS:

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

HGL Limited published this content on 23 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2021 00:09:06 UTC.